New Drug Approvals Archive - February 2014
Get news by email or subscribe to our news feeds.
February 2014
| February 12 |
New Indication Approved: February 12, 2014
Treatment for: Mantle Cell Lymphoma; Chronic Lymphocytic Leukemia; Waldenström’s Macroglobulinemia; Small Lymphocytic Lymphoma; Marginal Zone Lymphoma
Imbruvica (ibrutinib) FDA Approval History |
| February 14 |
Vimizim (elosufase alfa) Injection Date of Approval: February 14, 2014
Company: BioMarin Pharmaceutical Inc.
Treatment for: Mucopolysaccharidosis Type IVA
Vimizim (elosufase alfa) is an enzyme replacement therapy for patients with Mucopolysaccharidosis Type IVA (Morquio A syndrome). Vimizim (elosufase alfa) FDA Approval History |
| February 18 |
Northera (droxidopa) Capsules Date of Approval: February 18, 2014
Company: Chelsea Therapeutics International, Ltd.
Treatment for: Neurogenic Orthostatic Hypotension
Northera (droxidopa) is an orally active synthetic precursor of norepinephrine indicated for the treatment of neurogenic orthostatic hypotension. Northera (droxidopa) FDA Approval History |
| February 24 |
Myalept (metreleptin) Injection Date of Approval: February 24, 2014
Company: Amylin Pharmaceuticals, Inc.
Treatment for: Lipodystrophy
Myalept (metreleptin) is a leptin analog
indicated to treat the complications of leptin deficiency in patients with
congenital or acquired generalized lipodystrophy. Myalept (metreleptin) FDA Approval History |
| February 24 |
Tivorbex (indomethacin) Capsules Date of Approval: February 24, 2014
Company: Iroko Pharmaceuticals, LLC
Treatment for: Pain
Tivorbex (indomethacin) is a nonsteroidal anti-inflammatory drug (NSAID) indicated for the treatment of mild to moderate acute pain. Tivorbex (indomethacin) FDA Approval History |
| February 24 |
Monovisc (sodium hyaluronate) Injection Date of Approval: February 24, 2014
Company: Anika Therapeutics, Inc.
Treatment for: Osteoarthritis
Monovisc (sodium hyaluronate) is a viscoelastic supplement indicated for the treatment of pain associated with osteoarthritis of the knee. Monovisc (sodium hyaluronate) FDA Approval History |
New Drug Approvals Archive
2016
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December2015
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December2014
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December2013
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December2012
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December2011
January,
February,
March,
April,
May,
June,
July,
August,
October,
November,
December2010
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December2009
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December2008
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December2007
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December2006
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December2005
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December2004
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December2003
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December
